Published in J Thromb Haemost on April 01, 2012
Treatment options for venous thromboembolism: lessons learnt from clinical trials. Thromb J (2014) 0.95
Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood (2014) 0.94
Rivaroxaban for the treatment of pulmonary embolism. Adv Ther (2013) 0.81
Management of patients with unprovoked venous thromboembolism: an evidence-based and practical approach. Curr Treat Options Cardiovasc Med (2013) 0.79
XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis. Thromb J (2014) 0.77
The management of venous thromboembolism: A practical tool for the front-line clinician. Can Pharm J (Ott) (2017) 0.75
Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis. BMJ Open (2014) 0.75
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. J Thromb Haemost (2004) 1.14
Duration of anticoagulation for venous thromboembolism. J Thromb Thrombolysis (2001) 0.75